Oncology

Resource Center

Featured

FDA ALERT
FDA ALERT
08/26/2026
Anthony Calabro, MA
The FDA approved the first-in-class targeted therapy based on a clinical trial evaluating overall survival among adults with previously treated metastatic pancreatic adenocarcinoma.
08/26/2026
Expert Q&A
Expert Q&A
08/26/2026
Brady L. Stein, MD
At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
08/26/2026
Pop Quiz
Pop Quiz
08/25/2026
Anthony Calabro, MA
Five-year survival after Hodgkin lymphoma does not eliminate excess mortality risk. What does the long-term pattern of deaths reveal about survivorship after the disease?
08/25/2026

Interactive Features

Pop Quiz
Pop Quiz
08/25/2026
Anthony Calabro, MA
Five-year survival after Hodgkin lymphoma does not eliminate excess mortality risk. What does the long-term pattern of deaths reveal about survivorship after the disease?
08/25/2026
Photoclinic Challenge
Photoclinic Challenge
08/10/2026
Consultant360’s Photoclinic Challenge is an interactive quiz based on an image featured in a Photoclinic article. View the slideshow for a brief overview of the case, patient history, and a key hint.
08/10/2026
Pop Quiz
Pop Quiz
05/07/2026
Kate Young
SDM visits are a cornerstone of Medicare-covered lung cancer screening—but do you know how they influence whether patients return year after year? Take this brief quiz to test your knowledge!
05/07/2026
Pop Quiz
Pop Quiz
04/22/2026
Ashton L. Stahl
How much does a prior adenoma matter after age 75? Test your understanding of CRC risk vs competing mortality.
04/22/2026
Quiz Series
Quiz Series
03/05/2026
Anthony Calabro, MA
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
03/05/2026

Clinical Insights

Expert Q&A
Expert Q&A
08/26/2026
Brady L. Stein, MD
At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
08/26/2026
Case Report Insights
Case Report Insights
07/15/2026
Nandini N. Patel, BS
In this Consultant Case Report Insights, Nandini N. Patel, OMS III, provides an overview of her study, “Metastatic Malignant Melanoma from Unknown Origin to the Jejunum: A Case Report.” In the video...
07/15/2026
Editorial
Editorial
07/09/2026
Anthony Calabro, MA
Author-selected classifications for 2026 submissions highlight the breadth of practical, peer-reviewed, clinical education at Consultant, with dermatological disorders, pediatrics, primary care, cancer, and...
07/09/2026
Sponsored
Sponsored
05/18/2026
Fadi G. Haddad, MD
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
05/18/2026
Sponsored
Sponsored
04/21/2026
Fadi G. Haddad, MD
Monitoring treatment response in myelofibrosis requires a balanced assessment of patient-reported symptoms, objective scoring tools, hematologic parameters, and spleen size. In part 1 of this Myelofibrosis...
04/21/2026